Analyst Downgrade and Share Reaction
Amrize shares declined by more than 6% on Tuesday after Truist downgraded the building‑materials company from a Buy to a Hold rating and cut its price target from $65 to $48. The downgrade cited margin pressures in the commercial roofing segment and limited near‑term upside in cement pricing.
Financial Forecast Adjustments
Truist reduced its 2026 EBITDA estimate for Amrize to $3,199 million, down from $3,298 million, and based the new $48 price target on a 10.5‑times EV/EBITDA multiple.
Segment‑Specific Pressures
Analyst Keith Hughes highlighted that the commercial roofing business, which contributes roughly 28% of Amrize’s sales, is experiencing input inflation and price‑mix erosion that will persist through 2026. Cement, accounting for about 35% of sales, is expected to show positive volume trends but lacks pricing gains, limiting EBITDA improvement; a meaningful pricing recovery is not anticipated until 2027 at the earliest.
External Cost Drivers
The ongoing Iran conflict has pushed petrochemical prices higher, with MDI – a key roofing input – surging up to 73% after supply disruptions and force‑majeure declarations at major producers Dow and Covestro.
Competitive Landscape and Operational Risks
Hughes warned that Amrize is likely to remain confined to its post‑spin trading range, partly due to new competitive capacity in roofing. He flagged Kingspan’s entry into the U.S. non‑residential roofing market, where the competitor now operates two plants and plans a third, with the competitive impact expected to materialise in 2027.
Personnel Changes
Significant personnel shifts have occurred at Amrize since its spin‑off from Holcim, though Hughes noted that the effect of these changes on performance is difficult to quantify.